EPA Bans TCE, a Solvent Linked to PD

Posted on by Phil Franchina

In an exciting development for the Parkinsonโ€™s disease (PD) community, the Environmental Protection Agency (EPA) banned two solvents, trichloroethylene...see more (TCE) and perchloroethylene, that are found in many common industry and household products such as cleaners, lubricants, and glue. Both have been found to contribute to the increased risk of various cancers and other health conditions. […]

Read More

Vyalev: A Newly-Approved Medication for Parkinsonโ€™s Disease Motor Fluctuations

Posted on by Phil Franchina

Breaking news! The first subcutaneous (under the skin) 24-hour infusion...see more of foslevodopa/foscarbidopa under the brand name Vyalev, was approved by the Food and Drug Administration on Oct 17, 2024. Produced by AbbVie, this medication for the treatment of motor fluctuations in Parkinsonโ€™s disease (PD) has already […]

Read More

MAKING HOPE POSSIBLE: APDA FUNDS INNOVATIVE RESEARCH

Posted on by Phil Franchina

From genetic causes of PD to the neurobiology of cognitive dysfunction, APDA-funded...see more researchers begin new work. The American Parkinson Disease Association (APDA) recently awarded $2.6 million to support innovative Parkinsonโ€™s disease (PD) research for the 2024-2025 funding year. Exciting projects will tackle a wide range of key areas […]

Read More

FROM STIGMA TO SUPPORT: RETHINKING MENTAL HEALTH IN THE PD COMMUNITY

Posted on by Phil Franchina

Tremors, rigidity, and mobility issues are commonly associated...see more with Parkinsonโ€™s disease (PD). However, beneath the visible symptoms are many non-motor symptoms that are not always outwardly noticeable. One of these quieter yet equally important aspects of this disease are the mental health challenges that […]

Read More

WHATโ€™S HAPPENING AT APDA

Posted on by Phil Franchina

Falls Prevention Did you know that September was Falls Prevention Awareness Month? Throughout the month,...see more we raised awareness through social media, emails, and conversations with the PD community. Some common causes of falls in PD are postural instability, freezing of gait, festinating gait, orthostatic hypotension, and more. Physical therapy and medication […]

Read More

Making Hope Possible: American Parkinson Disease Associationย Supports Researchers With $2.6 Million in New Fundingย 

Posted on by Phil Franchina

Supports Researchers With $2.6 Million in New Funding  From genetic causes of Parkinsonโ€™s to the neurobiology of cognitive dysfunction,...see more APDA-funded researchers begin new work.  NEW YORK, NY, SEPTEMBER 4, 2024 โ€“ The American Parkinson Disease Association (APDA) has just awarded $2.6 million to support innovative Parkinsonโ€™s disease (PD) research for the 2024-2025 funding year โ€“ […]

Read More

Adaptive DBS โ€“ a new approach to improve PD symptoms

Posted on by Phil Franchina

Deep brain stimulation (DBS) is a surgical procedure in which thin electrodes are implanted into parts of the brain...see more to alter brain circuitry. It is used in the treatment of several neurologic conditions including Parkinsonโ€™s disease (PD), in which the electricity disrupts abnormal brain signals that allows the brain to restore more normal movement. Currently, […]

Read More

Recently published research on induced pluripotent stem cells by APDA-funded researchers

Posted on by Phil Franchina

APDA-funded researchers at Brigham and Womenโ€™s Hospital, including Drs. Isabel Lam and Anastasia Kuzkina, under the leadership of Dr. ...see more Vikram Khurana, the Director of APDAโ€™s Center for Advanced Research at Brigham and Womenโ€™s Hospital, recently published a paper demonstrating a novel technology that more rapidly turns stem cells created from the cells of an adult […]

Read More